SCHEMBL19960414

SCHEMBL19960414

B=P(C)(C)c1ccc2c(c1)c1ccccc1n1c3ccccc3nc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.47
MAPT P10636 7/20 0.47
LMNA P02545 4/20 0.47
POLB P06746 3/20 0.47
HSD17B10 Q99714 2/20 0.47
TP53 P04637 2/20 0.47
ALDH1A1 P00352 8/20 0.44
HPGD P15428 5/20 0.44
KMT2A Q03164 5/20 0.44
MEN1 O00255 3/20 0.44
TSHR P16473 2/20 0.40
SMN1; SMN2 Q16637 4/20 0.39
BCL2 P10415 1/20 0.38
CAMKK1 Q8N5S9 2/20 0.37
CAMKK2 Q96RR4 2/20 0.37
CSNK2A2 P19784 1/20 0.37
CSNK2B P67870 1/20 0.37
CSNK2A1 P68400 1/20 0.37
PIM3 Q86V86 1/20 0.37
DYRK2 Q92630 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22456534 0.88 KDM4E (0.48) KDM4EMAPTLMNAPOLBHSD17B10
SCHEMBL22456793 0.86 KDM4E (0.49) KDM4EMAPTLMNAPOLBHSD17B10
SCHEMBL22456531 0.84 KDM4E (0.47) KDM4EMAPTLMNAPOLBHSD17B10
SCHEMBL22456803 0.84 KDM4E (0.46) KDM4EMAPTLMNAPOLBHSD17B10
SCHEMBL22457022 0.84 KDM4E (0.47) KDM4EMAPTLMNAPOLBHSD17B10
SCHEMBL22456938 0.82 KDM4E (0.48) KDM4EMAPTLMNAPOLBHSD17B10
SCHEMBL22456536 0.82 KDM4E (0.48) KDM4EMAPTLMNAPOLBHSD17B10
SCHEMBL22456751 0.82 KDM4E (0.47) KDM4EMAPTLMNAPOLBHSD17B10
SCHEMBL17403790 0.82 KDM4E (0.47) KDM4EMAPTLMNAPOLBHSD17B10
SCHEMBL17403792 0.82 KDM4E (0.47) KDM4EMAPTLMNAPOLBHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, PER2 KDM4E 1997/4885MAPT 1310/4885LMNA 3023/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.